Riskpilot← Back to searchSign inGet full accessMedicQuant ApS
APSActiveCVR 40732829Palle Juul-Jensens Boulevard 82Manufacture of medical and dental instruments and supplies · NACE 3250Est. 201910 employees
Revenue 2024
DKK 1,1M
+78126% vs 2023
EBITDA margin
-96.3%
-60% vs 2023
Equity ratio
93.8%
Financial strength
Net profit 2024
DKK -501K
+46% vs 2023
| Revenue | DKK 1,1M | +78126% |
| EBITDA | DKK -1,1M | -60% |
| Net profit | DKK -501K | +46% |
| Total assets | DKK 11,4M | -4% |
| Equity | DKK 10,7M | -4% |
| Employees | 10 | — |
Legal name
MedicQuant ApS
CVR number
40732829
Legal form
Anpartsselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
22. august 2019
Share capital
DKK 127.098
Employees
10 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand i forening med en direktør eller af den samlede bestyrelse.
Company purpose
Virksomhedens formål er at udvikle og producere kemikalier, metoder, udstyr, knowhow og patent-rettigheder indenfor biosensorer og at kommercialisere disse rettigheder ved egne aktiviteter eller ved at lave licensaftaler med samarbejdspartnere, samt enhver aktivitet der står i forbindelse hermed.
Address
Palle Juul-Jensens Boulevard 82
Phone
+4531228410
Email
info@medicquant.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -103 | 0 | -91 | 1 | 1.094 |
| Staff expenses | -605 | -149 | -248 | -659 | -1.793 |
| EBITDA | -709 | -226 | -339 | -658 | -1.054 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -709 | -226 | -339 | -658 | -1.054 |
| Net financials | 700 | 301 | -2 | -10 | -2 |
| Profit before tax | -9 | 75 | -341 | -858 | -1.056 |
| Tax | -0 | -0 | -75 | 76 | -554 |
| Net profit | -9 | 75 | -266 | -934 | -501 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 232 | 311 | 212 | 11.874 | 11.447 |
| Equity | 36 | 144 | -122 | 11.244 | 10.742 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 195 | 167 | 334 | 384 | 464 |
| Total debt | 195 | 167 | 334 | 384 | 464 |
EBITDA margin
-96.3%
This company
15.8%
Market median
-709% vs market
20202024
Equity ratio
93.8%
This company
38.2%
Market median
+146% vs market
20202024
Return on equity
-4.7%
This company
18.4%
Market median
-126% vs market
20202024
Net profit margin
-45.8%
This company
8.1%
Market median
-665% vs market
20202024
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
20202024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2019-08-22 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LD Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
MH Management | Management | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2026 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Danmarks Eksport- og Investeringsfond | Company | 20.0% | 20.0% | 2023 |
Debois ApS | Company | 10.0% | 10.0% | 2026 |
Delphinus Venture Capital K/S | Company | 10.0% | 10.0% | 2026 |
BENGTSSON HOLDING ApS | Company | 10.0% | 10.0% | 2023 |
Bruhn Initiative ApS | Company | 10.0% | 10.0% | 2026 |
Gothelf ApS | Company | 5.0% | 5.0% | 2023 |
Waarst Holding ApS | Company | 5.0% | 5.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gothelf ApS
MedicQuant ApS Board members of MedicQuant ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Line Debois Frejlev Nielsen | Chief Executive Officer | 0 companies |
| Malthe Hansen-Bruhn | Management | 0 companies |
| Kurt Vesterager Gothelf | Chairman | 0 companies |
| Christian Jakob Anker-Ladefoged | Board of Directors | 0 companies |
| Kevin Leig Bengtsson | Chairman | 0 companies |
| Søren Danielsen Juhl | Board of Directors | 0 companies |
| Mathias Brink Lorenz | Board of Directors | 0 companies |